European recommendations for management of immune checkpoint inhibitors‐derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statement
暂无分享，去创建一个
G. Fabbrocini | M. Lacouture | C. Lebbé | A. Filoni | A. Freites-Martinez | L. Kraehenbuehl | P. Sollena | D. Fattore | V. Sibaud | V. Nikolaou | E. Lazaridou | K. Peris | B. Baroudjian | A. Stratigos | J. Riganti | Z. Apalla | E. Vigarios | R. Dodiuk-Gad | B. Richert | C. L. e | ISDIN. Gabriella Fabbrocini | Genesis Pharma. Vincent Sibaud | R. Dodiuk-Gad